Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 2Sarcoma 1Lymphoid 1

Conditions

Lymphoma 4Renal Insufficiency 2Osteosarcoma 2Lymphoma, Large B-Cell, Diffuse 2Leukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Neoplasms 1Mucositis 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Radiotherapy 2glucarpidase 1apraglutide 1angiotensin I (1-7) 1Methotrexate 1Leucovorin 1Gelclair 1Drug Therapy 12-(3',4'-dihydroxyphenyl-1-azo)benzimidazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mucositis × glucarpidase × Lymphoid × Clear all
NCT00727831 2014-01-27

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

University College, London

Phase 1/2 Completed
4 enrolled
LymphoidOther

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡